Michael O'RourkeCEO at RE-Vana Therapeutics, UKSpeaker
Agenda Sessions
Panel Discussion: What is the Optimal Dosing Window for Ocular Therapies?
08:35View Session
Panel Discussion: What is the Optimal Dosing Window for Ocular Therapies?